Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
13%(1 trials)

Phase Distribution

Ph phase_4
3
38%
Ph phase_1
1
13%
Ph phase_3
3
38%

Phase Distribution

1

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 3Large-scale testing
3(42.9%)
Phase 4Post-market surveillance
3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(8)

Detailed Status

Completed8

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (14.3%)
Phase 33 (42.9%)
Phase 43 (42.9%)

Trials by Status

completed8100%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_3

Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent

NCT00415805
completedphase_4

Multihance at 3 Tesla (3T) in Brain Tumors

NCT00395863
completed

Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients

NCT03147989
completedphase_4

Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the Brain

NCT00907530
completedphase_3

Multihance Versus Magnevist in Breast MRI

NCT00486473
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT00415805Phase 3

Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent

Completed
NCT00395863Phase 4

Multihance at 3 Tesla (3T) in Brain Tumors

Completed
NCT03147989

Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients

Completed
NCT00907530Phase 4

Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the Brain

Completed
NCT00486473Phase 3

Multihance Versus Magnevist in Breast MRI

Completed
NCT00408083Phase 3

Crossover Study With MultiHance vs a Comparator for Peripheral MRA

Completed
NCT00323102Phase 4

A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the Brain

Completed
NCT00411931Phase 1

A Pharmacokinetics Study of MultiHance in Pediatric Patients

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8